Micononin 50 mg and 100 mg Powder for concentrate for solution for infusion.
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment and prophylaxis of invasive candidiasis.
Dosage (summary)
Adults: 100 mg/day for invasive candidiasis; 150 mg/day for oesophageal candidiasis.
Special Populations
- Hepatic impairment
- Renal impairment
- Paediatric population
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- Sirolimus
- Nifedipine
- Itraconazole
Contraindications
- Hypersensitivity to micafungin
Common side effects
- Nausea
- Vomiting
- Phlebitis
- Increased liver enzymes
Counselling Points
- Monitor for liver function
- Report any rash or allergic reactions
- Avoid in lactose intolerance
Serious warnings
- Risk of liver tumors
- Anaphylactic reactions
- Severe hepatic dysfunction
The Micononin 50 mg and 100 mg Powder for concentrate for solution for infusion. professional information leaflet below is the property of Kahma Biotech and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.